BAJAJ BROKING

Notification close image
No new Notification messages
card image
Oswal Pumps IPO is Open!
Apply for the Oswal Pumps IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

543828

SUDARSHAN

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SUDARSHAN PHARMA INDUSTRIES LI Share Price Update

As of the latest trading session, SUDARSHAN PHARMA INDUSTRIES LI share price is currently at ₹ 29.99, which is down by ₹ -0.61 from its previous closing. Today, the stock has fluctuated between ₹ 29.99 and ₹ 29.99. Over the past year, SUDARSHAN PHARMA INDUSTRIES LI has achieved a return of 351.65 %. In the last month alone, the return has been 1.01 %. Read More...

SUDARSHAN PHARMA INDUSTRIES LI fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    721.70

  • P/E Ratio (TTM)

    45.44

  • Beta

    0.59

  • Book Value / share

    5.29

  • Return on equity

    10.69%

  • EPS (TTM)

    0.75

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.00

info icon alternate text

SUDARSHAN PHARMA INDUSTRIES LI Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Company Name Price P/E P/B Market Cap 52 Week Low/High
Company Name Price P/E P/B Market Cap 52 Week Low/High

SUDARSHAN PHARMA INDUSTRIES LI Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
29.99 -1.99 redarrow
red-green-graph indicator
15 Bearish
1 Bullish
  • 5 Days 30.80
  • 26 Days 30.60
  • 10 Days 31.00
  • 50 Days 30.70
  • 12 Days 30.90
  • 100 Days 31.90
  • 20 Days 30.70
  • 200 Days 30.60
30.60 PIVOT

First Support

30.60

First Resistance

30.60

Second Support

30.60

Second Resistance

30.60

Third Support

30.60

Third Resistance

30.60

RSI

46.20

ADX

39.93

MACD

0.35

Williams % R

-68.12

Commodity Channel Index (CCI)

-90.00

Date

2025-06-13

Week

96000.00

Same Day

8000.00

Month

156500.00

1 Year

0.59

3 Year

0.54

Over 1 Month

1.01%

down

Over 1 Year

351.65%

down

Over 3 Months

3.41%

down

Over 3 Years

62.88%

down

Over 6 Months

-30.14%

down

Over 5 Years

0.00%

down

SUDARSHAN PHARMA INDUSTRIES LI shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

SUDARSHAN PHARMA INDUSTRIES LI corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
25 Aug 2023 0.3 Final 26 Aug 2023 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

SUDARSHAN PHARMA INDUSTRIES LI Share Price

Sudarshan Pharma Industries Limited was originally incorporated as a Private Limited Company with the name 'Sudarshan Specialty Chemsolve Private Limited' on July 23, 2008 with the Registrar of Companies, Mumbai. Later in the year 2016. name of the Company was changed from 'Sudarshan Specialty Chemsolve Private Limited' to 'Sudarshan Pharma Industries Private Limited' on 17 December 2016. Thereafter, the Company converted into a Public Limited pursuant to a special resolution passed by shareholders at the EGM held on December 12, 2016 and consequently, name of the Company was changed to 'Sudarshan Pharma Industries Limited' on January 5, 2017.

The Company was promoted by Mr. Hemal V. Mehta & Mr. Sachin V. Mehta, who have a combined experience of over 25 years in the Special Chemical, Bulk drug and Pharmaceutical Industry. At present, Company is into Specialty Chemicals & Intermediates for Pharma, agro chemicals, Coating, various other industries. We are also into Active Pharmaceuticals Ingredients manufacturing. Our main focus is on Vitamin and API. The Company has setup its Unit at Palghar, Maharashtra. Key activities at this unit includes testing of raw materials to dispensing raw materials for formulations, to batch manufacturing as per approved standards, to packing of finished formulations, to storage and dispatch. Maharashtra Government policies and subsidies for new project is supportive and eases the initial financial burden required for setting up a large scale manufacturing unit.

The Company outsources its manufacturing facility, deal in Import and Exports, indenting and Supply in Specialty chemicals, API & its intermediate. As per the clients need and requirement, the company provides order and get them manufactured from various suppliers in India and abroad regularly. Specialty chemicals and Intermediates having wide application in pharma, paint, food and adhesive Industry. It is also involved in Contract Manufacturing, outsource & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals. It also offer services of QC and Formulation Development to provide customised solutions to our customers and assist them in sourcing the innovative products as per their needs.

The Company carries about Ethical marketing of Pharmaceutical formulation & products in the Domestic and International market through distribution network and Sales force under its own brand. Presently, the Company has joined hands with regular suppliers having FDA and WHO approved plant along with their own unit to supply pharma formulation and more than 100 generic pharma products. These units manufacture tablets, capsules, dry powder, dry injections powder, liquids, Injections & dry injections for their own brands.

Apart from these, the Company has launched wide products range in pharma formulation such as Setdown, Pulmo relief, Fix Pollen, Flupimac and has established goodwill for quality products and have regular clients for the same. Further, it supplies generic pharmaceutical formulation as Make to order for bulk supply to the hospital, Health Centre of Corporate, Municipality and exports.

The Company operate both in domestic and international markets. Presently, it is supplying Active Pharmaceutical Ingredients
(APIs), Intermediates Finished Dosage Formulations (FDFs) and Specialty Chemicals (SCs) in the domestic markets. It has entered into MOU / Agreements with Storage Houses / Warehouses facility providers at Bhiwandi Thane, Maharashtra, Wada Palghar, Maharashtra and Baddi, Himachal Pradesh for using their premises for the stock keeping of the products. The Company has also entered into Lease Agreement with Group Company, Sudarshan Chempharm LLP for using its premises and land to set up proposed Manufacturing and Storage / Warehouse Facility at Wada, in Maharashtra.

In domestic pharmaceuticals markets, currently, the Company has good presence and is servicing through a Supply Chain Network of Consignee Agents with products range. It also provide onsite support & assistance to clients using their Drug Intermediates and Specialty Chemicals.

The Company made an Initial Public Offer by issuing 68,62,400 Equity Shares of face value of Rs 10 each by raising funds aggregating to Rs. 50 Crore, through Fresh Issue in March, 2023.

Ratna Lifesciences Private Limited was incorporated as a wholly owned subsidiary company on November 10, 2023. The Company achieved development of the molecule VITAMIN B6 (Pyridoxine Hydrochloride) from base root till the finished product and also manufactured all the intermediary products required to manufacture the finished API products of 'VITAMIN B6'. It also achieved first milestone in developing the sample for the molecule VITAMIN B1 (Thiamine Hydrochloride) from Base Root for Manufacturing Process of 'VITAMIN B1'. Life Science Chemical was incorporated on August 23, 2023.

Parent organization Indian Private
NSE symbol [-]
Founded 2008
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Sudarshan Pharma Industries Ltd?

Answer Field

The share price of Sudarshan Pharma Industries Ltd for NSE is ₹ 0.00 and for BSE is ₹ 29.99.

What is the Market Cap of Sudarshan Pharma Industries Ltd?

Answer Field

The market cap of Sudarshan Pharma Industries Ltd for NSE is ₹ 0.00 Cr. and for BSE is ₹ 721.70 Cr. as of now.

What is the 52 Week High and Low of Sudarshan Pharma Industries Ltd?

Answer Field

The 52 Week High and Low of Sudarshan Pharma Industries Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 53.50 and ₹ 6.60.

How to Buy Sudarshan Pharma Industries Ltd share?

Answer Field

You can trade in Sudarshan Pharma Industries Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Sudarshan Pharma Industries Ltd?

Answer Field

The 1 year returns on the stock has been 351.65%.

What is the Current Share Price of Sudarshan Pharma Industries Ltd?

Answer Field

Sudarshan Pharma Industries Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 29.99 as on Jun 13 2025 02:15 PM.

What is the Market Cap of Sudarshan Pharma Industries Ltd Share?

Answer Field

The market cap of Sudarshan Pharma Industries Ltd for NSE ₹ 0.00 & for BSE ₹ 721.70 as on Jun 13 2025 02:15 PM.

What is the P/E Ratio of Sudarshan Pharma Industries Ltd Share?

Answer Field

As on Jun 13 2025 02:15 PM the price-to-earnings (PE) ratio for Sudarshan Pharma Industries Ltd share is 45.44.

What is the PB ratio of Sudarshan Pharma Industries Ltd Share?

Answer Field

As on Jun 13 2025 02:15 PM, the price-to-book (PB) ratio for Sudarshan Pharma Industries Ltd share is 5.29.

How to Buy Sudarshan Pharma Industries Ltd Share?

Answer Field

You can trade in Sudarshan Pharma Industries Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Sudarshan Pharma Industries Ltd Share on Bajaj Broking App?

Answer Field

To buy Sudarshan Pharma Industries Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sudarshan Pharma Industries Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|